Reduced CD18 levels drive regulatory T cell conversion into Th17 cells in the CD18hypo PL/J mouse model of psoriasis

Journal of Immunology

Volumn 190, Issue 6, 2013, Pages 2544-2553

  Singh, Kamayani ^a   Gatzka, Martina ^a   Peters, Thorsten ^d   Borkner, Lisa ^b   Hainzl, Adelheid ^d   Wang, Honglin ^c   Sindrilaru, Anca ^d   Karin, Scharffetter Kochanek ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD18 ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 2; NEUTRALIZING ANTIBODY; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR FOXP3;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL INFILTRATION; COCULTURE; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPENSITY SCORE; PSORIASIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; TH17 CELL; UPREGULATION;

ANIMALS; ANTIGENS, CD18; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HUMANS; IMMUNOPHENOTYPING; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MICE, TRANSGENIC; PSORIASIS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84874890576     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202399     Document Type: Article

References (50)

1. Schön, M. P., and W. H. Boehncke. 2005. Psoriasis. N. Engl. J. Med. 352: 1899- 1912
2. Nickoloff, B. J. 1999. The immunologic and genetic basis of psoriasis. Arch. Dermatol. 135: 1104-1110
3. Nickoloff, B. J., and F. O. Nestle. 2004. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. J. Clin. Invest. 113: 1664-1675
4. Schön, M. P., M. Detmar, and C. M. Parker. 1997. Murine psoriasis-like disorder induced by naive CD4+ T cells. Nat. Med. 3: 183-188
5. Sugiyama, H., R. Gyulai, E. Toichi, E. Garaczi, S. Shimada, S. R. Stevens, Sr., T. S. McCormick, and K. D. Cooper. 2005. Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation. J. Immunol. 174: 164-173
6. Wang, H., T. Peters, A. Sindrilaru, D. Kess, T. Oreshkova, X. Z. Yu, A. M. Seier, H. Schreiber, M. Wlaschek, R. Blakytny, et al. 2008. TGF-β-dependent suppressive function of Tregs requires wild-type levels of CD18 in a mouse model of psoriasis. J. Clin. Invest. 118: 2629-2639
7. Yun, W. J., D. W. Lee, S. E. Chang, G. S. Yoon, J. R. Huh, C. H. Won, M. W. Lee, S. E. Kim, B. J. Kim, K. C. Moon, and J. H. Choi. 2010. Role of CD4CD25FOXP3 regulatory T cells in psoriasis. Ann. Dermatol. 22: 397-403
8. Sakaguchi, S., T. Yamaguchi, T. Nomura, and M. Ono. 2008. Regulatory T cells and immune tolerance. Cell 133: 775-787
9. Josefowicz, S. Z., L. F. Lu, and A. Y. Rudensky. 2012. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30: 531- 564
10. Harrington, L. E., R. D. Hatton, P. R. Mangan, H. Turner, T. L. Murphy, K. M. Murphy, and C. T. Weaver. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132
11. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141
12. Goodman, W. A., A. D. Levine, J. V. Massari, H. Sugiyama, T. S. McCormick, and K. D. Cooper. 2009. IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. J. Immunol. 183: 3170-3176
13. Rizzo, H. L., S. Kagami, K. G. Phillips, S. E. Kurtz, S. L. Jacques, and A. Blauvelt. 2011. IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A. J. Immunol. 186: 1495-1502
14. Korn, T., E. Bettelli, M. Oukka, and V. K. Kuchroo. 2009. IL-17 and Th17 Cells. Annu. Rev. Immunol. 27: 485-517
15. Wilson, R. W., C. M. Ballantyne, C. W. Smith, C. Montgomery, A. Bradley, W. E. O'Brien, and A. L. Beaudet. 1993. Gene targeting yields a CD18-mutant mouse for study of inflammation. J. Immunol. 151: 1571-1578
16. Bullard, D. C., K. Scharffetter-Kochanek, M. J. McArthur, J. G. Chosay, M. E. McBride, C. A. Montgomery, and A. L. Beaudet. 1996. A polygenic mouse model of psoriasiform skin disease in CD18-deficient mice. Proc. Natl. Acad. Sci. USA 93: 2116-2121
17. Kess, D., T. Peters, J. Zamek, C. Wickenhauser, S. Tawadros, K. Loser, G. Varga, S. Grabbe, R. Nischt, C. Sunderkö tter, et al. 2003. CD4+ T cell-associated pathophysiology critically depends on CD18 gene dose effects in a murine model of psoriasis. J. Immunol. 171: 5697-5706
18. Wang, H., T. Peters, D. Kess, A. Sindrilaru, T. Oreshkova, N. Van Rooijen, A. Stratis, A. C. Renkl, C. Sunderkötter, M. Wlaschek, et al. 2006. Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. J. Clin. Invest. 116: 2105-2114
19. Hynes, R. O. 1987. Integrins: a family of cell surface receptors. Cell 48: 549- 554
20. Carlos, T. M., and J. M. Harlan. 1994. Leukocyte-endothelial adhesion molecules. Blood 84: 2068-2101
21. Wang, H., D. Kess, A. K. Lindqvist, T. Peters, A. Sindrilaru, M. Wlaschek, R. Blakytny, R. Holmdahl, and K. Scharffetter-Kochanek. 2008. A 9-centimorgan interval of chromosome 10 controls the T cell-dependent psoriasiform skin disease and arthritis in a murine psoriasis model. J. Immunol. 180: 5520-5529
22. van de Kerkhof, P. C., and C. M. Weemaes. 1990. Skin manifestations in congenital deficiency of leucocyte-adherence glycoproteins (CDLG). Br. J. Dermatol. 123: 395-401
23. Tomfohrde, J., A. Silverman, R. Barnes, M. A. Fernandez-Vina, M. Young, D. Lory, L. Morris, K. D. Wuepper, P. Stastny, A. Menter, et al. 1994. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 264: 1141-1145
24. Bovenschen, H. J., P. C. van de Kerkhof, P. E. van Erp, R. Woestenenk, I. Joosten, and H. J. P. M. Koenen. 2011. Foxp3+ regulatory T cells of psoriasis patients easily differentiate into IL-17A-producing cells and are found in lesional skin. J. Invest. Dermatol. 131: 1853-1860
25. Koenen, H. J. P. M., R. L. Smeets, P. M. Vink, E. van Rijssen, A. M. H. Boots, and I. Joosten. 2008. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112: 2340-2352
26. Brucklacher-Waldert, V., K. Steinbach, M. Lioznov, M. Kolster, C. Hölscher, and E. Tolosa. 2009. Phenotypical characterization of human Th17 cells unambiguously identified by surface IL-17A expression. J. Immunol. 183: 5494-5501
27. Ueda, A., L. Zhou, and P. L. Stein. 2012. Fyn promotes Th17 differentiation by regulating the kinetics of RORgt and Foxp3 expression. J. Immunol. 188: 5247- 5256
28. Chen, Y., C. J. Haines, I. Gutcher, K. Hochweller, W. M. Blumenschein, T. McClanahan, G. Hämmerling, M. O. Li, D. J. Cua, and M. J. McGeachy. 2011. Foxp3(+) regulatory T cells promote T helper 17 cell development in vivo through regulation of interleukin-2. Immunity 34: 409-421
29. Marski, M., S. Kandula, J. R. Turner, and C. Abraham. 2005. CD18 is required for optimal development and function of CD4+CD25+ T regulatory cells. J. Immunol. 175: 7889-7897
30. Horwitz, D. A., S. G. Zheng, and J. D. Gray. 2008. Natural and TGF-betainduced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Trends Immunol. 29: 429-435
31. Lebwohl, M. 2003. Psoriasis. Lancet 361: 1197-1204
32. El-Sayed, Z. A., D. H. El-Ghoneimy, H. Abd-Allah, and H. M. Afifi. 2011. A rare association between leukocyte adhesion deficiency type I and psoriasis in humans. Allergy Asthma Immunol. Res. 3: 138-140
33. van Pelt, J. P. A., S. H. H. Kuijpers, P. C. M. van de Kerkhof, and E. M. G. J. de Jong. 1998. The CD11b/CD18-integrin in the pathogenesis of psoriasis. J. Dermatol. Sci. 16: 135-143
34. Talamonti, M., G. Spallone, A. Di Stefani, A. Costanzo, and S. Chimenti. 2011. Efalizumab. Expert Opin. Drug Saf. 10: 239-251
35. Kess, D., A. K. Lindqvist, T. Peters, H. Wang, J. Zamek, R. Nischt, K. W. Broman, R. Blakytny, T. Krieg, R. Holmdahl, and K. Scharffetter- Kochanek. 2006. Identification of susceptibility loci for skin disease in a murine psoriasis model. J. Immunol. 177: 4612-4619
36. Wirnsberger, G., M. Hinterberger, and L. Klein. 2011. Regulatory T-cell differentiation versus clonal deletion of autoreactive thymocytes. Immunol. Cell Biol. 89: 45-53
37. Gatzka, M. G., R. H. Newton, and C. M. Walsh. 2009. Altered thymic selection and increased autoimmunity caused by ectopic expression of DRAK2 during T cell development. J. Immunol. 183: 285-297
38. Bachmann, M. F., K. McKall-Faienza, R. Schmits, D. Bouchard, J. Beach, D. E. Speiser, T. W. Mak, and P. S. Ohashi. 1997. Distinct roles for LFA-1 and CD28 during activation of naive T cells: adhesion versus costimulation. Immunity 7: 549-557
39. Wuest, T. Y., J. Willette-Brown, S. K. Durum, and A. A. Hurwitz. 2008. The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells. J. Leukoc. Biol. 84: 973-980
40. Cheng, G., A. Yu, and T. R. Malek. 2011. T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells. Immunol. Rev. 241: 63-76
41. Wei, L., A. Laurence, and J. J. O'Shea. 2008. New insights into the roles of Stat5a/b and Stat3 in T cell development and differentiation. Semin. Cell Dev. Biol. 19: 394-400
42. Lio, C. W., and C. S. Hsieh. 2008. A two-step process for thymic regulatory T cell development. Immunity 28: 100-111
43. Ziegler, S. F., and J. H. Buckner. 2009. FOXP3 and the regulation of Treg/Th17 differentiation. Microbes Infect. 11: 594-598
44. Yang, X. O., R. Nurieva, G. J. Martinez, H. S. Kang, Y. Chung, B. P. Pappu, B. Shah, S. H. Chang, K. S. Schluns, S. S. Watowich, et al. 2008. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29: 44-56
45. Sather, B. D., P. Treuting, N. Perdue, M. Miazgowicz, J. D. Fontenot, A. Y. Rudensky, and D. J. Campbell. 2007. Altering the distribution of Foxp3(+) regulatory T cells results in tissue-specific inflammatory disease. J. Exp. Med. 204: 1335-1347
46. Debes, G. F., C. N. Arnold, A. J. Young, S. Krautwald, M. Lipp, J. B. Hay, and E. C. Butcher. 2005. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues. Nat. Immunol. 6: 889-894
47. Bromley, S. K., T. R. Mempel, and A. D. Luster. 2008. Orchestrating the orchestrators: chemokines in control of T cell traffic. Nat. Immunol. 9: 970-980
48. Quintana, F. J., A. S. Basso, A. H. Iglesias, T. Korn, M. F. Farez, E. Bettelli, M. Caccamo, M. Oukka, and H. L. Weiner. 2008. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 453: 65-71
49. Zhou, L., J. E. Lopes, M. M. Chong, I. I. Ivanov, R. Min, G. D. Victora, Y. Shen, J. Du, Y. P. Rubtsov, A. Y. Rudensky, et al. 2008. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453: 236-240
50. Xu, L., A. Kitani, I. Fuss, and W. Strober. 2007. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-β. J. Immunol. 178: 6725-6729